Pharmacy coalition to Trump administration: Meet with us about opioid crisis
APhA’s Menighan underscores critical role of pharmacists in the fight
The National Conference of Pharmaceutical Organizations (NCPO), a coalition of organizations representing more than 300,000 pharmacy practitioners, pharmaceutical scientists, pharmacy regulators, and pharmacy educators, has invited the Trump administration to meet to discuss ways of addressing the nation’s opioid crisis. Noting that each day more than 90 Americans die from overdosing on opioids, the coalition, of which APhA is a part, said in a statement that it supports immediate action on components of the report of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.
"We ask the White House and the Administration to work with the pharmacy community to establish and implement specific programs to address this crisis, and to identify specific goals for these programs,” said Lucinda L. Maine, PhD, RPh, executive vice president and CEO of the American Association of Colleges of Pharmacy and NCPO president.
In a related statement, APhA executive president and CEO Thomas E. Menighan, BSPharm, MBA, ScD (Hon.), FAPhA, said, “APhA, along with the other NCPO members, is individually and jointly committed to combating this public health crisis as we implement best practices across the country. We believe such collaborative efforts are essential to meeting our country’s needs for high quality health care while working together to reduce the impact of this crisis on American families.”
Menighan highlighted pharmacists’ long-standing contributions in the fight against opioid misuse and abuse. “We work actively with patients and their communities on a daily basis, and APhA’s priority is to make sure that policy makers and our fellow health care providers know what pharmacists can do to make meaningful progress in the fight against opioids.”